Showing posts with label Pacemaker Market. Show all posts
Showing posts with label Pacemaker Market. Show all posts

Friday, 27 May 2022

Pacemaker Market to Grow at a CAGR of 6.06% through 2027

 Increasing prevalence of cardiovascular diseases and technological advancement in medical devices are some key factors driving the growth of global pacemaker market.



According to TechSci Research report, Pacemaker Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global pacemaker market stood at USD5.01 billion in 2021 and is expected to grow at a CAGR of 6.06% during the forecast period on account of the growing prevalence of cardiovascular diseases and technological advancements in medical devices.

The growing demand for pacemakers from various point of care diagnostic centers, hospitals, among others, is expected to support the market growth through 2027. The growing prevalence of various cardiovascular diseases and aging population have significantly increased the patient pool worldwide suffering from these diseases. This, in turn, has significantly increased the demand for various pacemakers in all the countries. Further, increasing expenditure on the healthcare sector and availability of medical coverage are also driving the growth of the global pacemaker market. Technological advancements such as leadless pacemakers and MRI-compatible pacemakers also contribute to the market growth of pacemakers worldwide.

However, the high cost of advanced pacemakers leads to affordability constraints, especially in developing countries of Asia Pacific, South America, and the Middle East & Africa. Also, infection risk through leads and privacy concerns related to advanced pacemakers hinder the growth of the pacemaker market globally. Furthermore, the presence of alternative treatments like cardioverter defibrillators and cardiac ablation-catheters is posing a challenge for the global pacemaker market and hinders its growth during the forecast period.

Browse over 199 market data Figures spread through 110 Pages and an in-depth TOC on "Global Pacemaker Market"

https://www.techsciresearch.com/report/pacemaker-market/9500.html

The global pacemaker market is segmented on the basis of type, technology, product type, application, end user, company, and regional distribution. In terms of type, the market can be divided into Implantable and External. The implantable pacemaker segment dominated the market in 2020 with around 82.35% because these pacemakers are long-lasting and have fewer post-operative complications than external pacemakers. In terms of technology, the market can be categorized into Dual Chamber, Single Chamber and Biventricular Chamber. The dual chamber technology is expected to dominate the market during the forecast period as it is most common and has two leads that mimic the sequential physiological contraction of the atria and ventricles. Based on product type, the market is divided into MRI Compatible and Conventional. MRI Compatible Pacemakers hold the largest share as all the pacemakers that are available in the market nowadays are MRI Compatible. Conventional Pacemakers are not used by the surgeons and physicians due to the amount of risk associated with it. In terms of application, the market can be fragmented into Arrythmias, Congestive Heart Failure and others. In terms of applications, Arrythmias dominate the market due to the growing prevalence of arrythmias conditions all over the world. Based on end user, the market can be segmented into hospitals, ambulatory surgery centers, and others. Hospitals dominate the market in terms of end users. However, due to COVID-19, the share of hospitals declined as many surgeries were postponed in 2020.

Key market players in the global pacemaker market include:

  • Medtronic Inc
  • Boston Scientific Corporation
  • Sorin Group
  • Abbott Laboratories Inc
  • Edwards Lifesciences Corporation
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Philips Healthcare
  • GE Healthcare Inc
  • Microport Scientific Corp

Medtronic Plc holds the highest market share and is among the top five market players operating in the pacemaker market globally. Boston Scientific Corporation ranks second in terms of market share in the overall pacemaker market. This can be attributed to the company’s strong presence worldwide through subsidiaries, sales offices, distributors, suppliers and other channel partners. Population in emerging countries are also aware of the presence, product portfolio and business of the company and prefer them over other competitor brands.

Additionally, there are other prominent players, such as Abbott Laboratories, Biotronik, Sorin Group, B. Braun Melsungen AG, among others, holding a significant position in the global pacemaker market.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=9500

Customers can also request for 10% free customization on this report.

“The Asia Pacific region is expected to register the highest growth in the Pacemaker market during the forecast period. This can be attributed to the growing incidences of arrythmia, especially in countries like China, India, and Japan. Additionally, countries like China and India are moving towards localization, and in the coming years, it can be witnessed that a lot of domestic players are emerging out from these companies and holding significant market positions.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

Pacemaker Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Implantable v/s External), By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type (MRI Compatible v/s Conventional), By Applications (Arrythmias, Congestive Heart Failure, Others), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers), By Company (2021), By Region”, has evaluated the future growth potential of global pacemakers and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global pacemaker market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com

Friday, 23 July 2021

United States Pacemaker Market to Register Healthy Growth through 2025 | TechSci Research

Increasing cases of cardiovascular diseases and technological advancements in healthcare to drive United States pacemaker market.

US Pacemaker Market - TechSci Research
According to TechSci Research report, United States Pacemaker Market By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application (Heart Block, Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia,  Long QT Syndrome), By Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers), By Region, Forecast & Opportunities, 2025”, the market is anticipated to grow at a significant CAGR during the forecast period. Key factors propelling the growth of United States pacemaker market include increasing prevalence of cardiovascular diseases and the spread of COVID-19, which has led to high spread of CVDs among patients suffering from coronavirus. The increasing demand for minimally invasive procedures is also creating high demand for pacemakers in United States market. Furthermore, technological advancements and launch of new products such as leadless pacemakers and MRI safe pacemakers are expected to propel the market growth in coming years. Also, favorable government policies and increasing expenditure on healthcare sector are supporting the growth of US pacemaker market.

Additionally, favorable reimbursement procedures such as Medicare system coupled with rise in manufacturing high-end pacemakers, which caters to customized care are fueling the growth of United States pacemaker market. Along with this, growing geriatric population who are more vulnerable to cardiovascular diseases is also acting as a major growth driver for this market. The advent of battery free pacemakers has brough revolutionary change in the market and is augmenting the market growth. With increasing FDA approval for novel pacemakers, the market is expected to witness substantial growth through 2025. However, pacemaker devices cost two to six times more in the United States than in European countries such as Germany. This might hinder the United States pacemaker market growth.

Browse XX market data Tables and XX Figures spread through XX Pages and an in-depth TOC on "United States Pacemaker Market"

https://www.techsciresearch.com/report/united-states-pacemaker-market/5173.html

The United States pacemaker market is segmented based on type, product type, application, technology, end user and region. Based on application, the market can be segmented into heart block, arrhythmia, atrial fibrillation, bradycardia, tachycardia, and long QT syndrome. Among them, atrial fibrillation is expected to hold a significant share in US pacemaker market during the forecast period. According to CDC, around 2.7–6.1 million people in the United States have atrial fibrillation, which is the most common type of heart arrhythmia. The number is expected to increase over the coming years.

Based on technology, US pacemaker market can be segmented into single chamber, dual chamber and CRT-P/biventricular pacemakers. Among them, dual-chamber pacemakers held significant share in United States market in 2019, owing to reduced post-surgical complications and presence of two leads which assure normal physiology of the heart. However, CRT-P, also known as biventricular pacemakers, are expected to register fastest growth in US pacemaker market during the forecast period as they are increasingly being used to treat people with arrhythmias caused by advanced heart failure. These pacemakers contain three leads which are connected to the right atrium and both ventricles.

Major players operating in the United States pacemaker market include Biotronik, Inc., Boston Scientific Corporation, Abbot Inc., Zoll Medical Corporation, Oscor Inc., Medtronic, Inc., Cordis, Inc., Livanova PLC, Medico Inc., Oscor Inc. and Osypka Medical Inc. Leading companies are undertaking growth strategies such as new product launches, mergers & acquisitions and partnerships.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5173

Customers can also request for 10% free customization on this report.

“The introduction of U.S. Food and Drug Administration (FDA)-cleared MRI-conditional pacemaker models are a growing trend in United States. Around 20% of pacemaker patients need an MRI within the first two years of implant. Pacemakers which do not have MRI-conditional use technology, generally prevent patients from being able to get an MRI. With increasing cases of cardiovascular diseases in the country, more manufacturers are coming up with advanced products and are using MRI-conditional use technology,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“United States Pacemaker Market By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application (Heart Block, Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia,  Long QT Syndrome), By Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of US pacemaker market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in United States pacemaker market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/